Switch theme
Sign up to access all valuation multiples
Exosens SA is a high-tech company in innovation, development, manufacturing and sale of high-end electro-optical technologies in the field of amplification, detection and imaging. It offers its customers detection components and solutions such as travelling wave tubes, advanced cameras, neutron & gamma detectors, instrument detectors and light intensifier tubes. Its products include Night vision tubes, Ultra Violet cameras, Ion and electron detection, Gamma detectors, etc.
2021
1.2K+
LTM Revenue $445M
LTM EBITDA $131M
$1.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Exosens has a last 12-month revenue of $445M and a last 12-month EBITDA of $131M.
In the most recent fiscal year, Exosens achieved revenue of $423M and an EBITDA of $124M.
Exosens expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Exosens valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $342M | $423M | XXX | XXX | XXX |
| Gross Profit | $122M | $190M | XXX | XXX | XXX |
| Gross Margin | 36% | 45% | XXX | XXX | XXX |
| EBITDA | $90.1M | $124M | XXX | XXX | XXX |
| EBITDA Margin | 26% | 29% | XXX | XXX | XXX |
| Net Profit | $12.0M | $18.4M | XXX | XXX | XXX |
| Net Margin | 4% | 4% | XXX | XXX | XXX |
| Net Debt | $226M | $307M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Exosens's stock price is EUR 32 (or $35).
Exosens has current market cap of EUR 1.6B (or $1.8B), and EV of EUR 1.5B (or $1.6B).
See Exosens trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.6B | $1.8B | XXX | XXX | XXX | XXX | $1.21 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Exosens has market cap of $1.8B and EV of $1.6B.
Exosens's trades at 3.6x LTM EV/Revenue multiple, and 12.3x LTM EBITDA.
Analysts estimate Exosens's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Exosens and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.6B | XXX | XXX | XXX |
| EV/Revenue | 3.8x | XXX | XXX | XXX |
| EV/EBITDA | 13.0x | XXX | XXX | XXX |
| P/E | 53.3x | XXX | XXX | XXX |
| P/E/Growth | 0.8x | XXX | XXX | XXX |
| EV/FCF | 15.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpExosens's NTM/LTM revenue growth is 16%
Exosens's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Exosens's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Exosens's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Exosens and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 24% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 37% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 45% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 38% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| ASML | XXX | XXX | XXX | XXX | XXX | XXX |
| Besi | XXX | XXX | XXX | XXX | XXX | XXX |
| Signify | XXX | XXX | XXX | XXX | XXX | XXX |
| Nedap | XXX | XXX | XXX | XXX | XXX | XXX |
| TKH Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Exosens acquired XXX companies to date.
Last acquisition by Exosens was XXXXXXXX, XXXXX XXXXX XXXXXX . Exosens acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Exosens founded? | Exosens was founded in 2021. |
| Where is Exosens headquartered? | Exosens is headquartered in France. |
| How many employees does Exosens have? | As of today, Exosens has 1.2K+ employees. |
| Is Exosens publicy listed? | Yes, Exosens is a public company listed on PAR. |
| What is the stock symbol of Exosens? | Exosens trades under EXENS ticker. |
| When did Exosens go public? | Exosens went public in 2024. |
| Who are competitors of Exosens? | Similar companies to Exosens include e.g. ASML, Besi, Signify, Nedap. |
| What is the current market cap of Exosens? | Exosens's current market cap is $1.8B |
| What is the current revenue of Exosens? | Exosens's last 12-month revenue is $445M. |
| What is the current EBITDA of Exosens? | Exosens's last 12-month EBITDA is $131M. |
| What is the current EV/Revenue multiple of Exosens? | Current revenue multiple of Exosens is 3.6x. |
| What is the current EV/EBITDA multiple of Exosens? | Current EBITDA multiple of Exosens is 12.3x. |
| What is the current revenue growth of Exosens? | Exosens revenue growth between 2023 and 2024 was 24%. |
| Is Exosens profitable? | Yes, Exosens is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
